高级检索

中药熏洗治疗结直肠癌患者化疗后手足综合征的疗效观察

程小伟, 吴锐荣, 张振勇, 朱娅

程小伟, 吴锐荣, 张振勇, 朱娅. 中药熏洗治疗结直肠癌患者化疗后手足综合征的疗效观察[J]. 实用临床医药杂志, 2020, 24(21): 32-35. DOI: 10.7619/jcmp.202021010
引用本文: 程小伟, 吴锐荣, 张振勇, 朱娅. 中药熏洗治疗结直肠癌患者化疗后手足综合征的疗效观察[J]. 实用临床医药杂志, 2020, 24(21): 32-35. DOI: 10.7619/jcmp.202021010
shu
CHENG Xiaowei, WU Ruirong, ZHANG Zhenyong, ZHU Ya. Clinical efficacy of herbal fumigation on hand-foot syndrome after chemotherapy in colorectal cancer patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(21): 32-35. DOI: 10.7619/jcmp.202021010
Citation: CHENG Xiaowei, WU Ruirong, ZHANG Zhenyong, ZHU Ya. Clinical efficacy of herbal fumigation on hand-foot syndrome after chemotherapy in colorectal cancer patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(21): 32-35. DOI: 10.7619/jcmp.202021010
shu

中药熏洗治疗结直肠癌患者化疗后手足综合征的疗效观察

  • 江南大学附属医院/江苏省无锡市第三人民医院, 江苏 无锡, 214000

详细信息

  • 中图分类号: R735

Clinical efficacy of herbal fumigation on hand-foot syndrome after chemotherapy in colorectal cancer patients

  • Affiliated Hospital of Jiangnan University, Wuxi City Third People's Hospital in Jiangsu Province, Wuxi, Jiangsu, 214000

摘要

    摘要
  • 摘要: 目的 观察中药熏洗治疗卡培他滨化疗后手足综合征的疗效。 方法 选取因口服卡培他滨出现Ⅱ级手足综合征的结直肠癌患者84例,随机分为治疗组和对照组,每组42例。对照组给予口服维生素B6及甲钴胺治疗; 治疗组在口服药物治疗的基础上加用中药熏洗治疗,比较2组治疗后疗效情况。 结果 对照组总有效率64.3%, 其中治愈率38.1%; 治疗组总有效率90.5%, 其中治愈率66.7%, 2组总有效率、治愈率差异具有统计学意义(P<0.05)。 结论 针对卡培他滨化疗后手足综合征患者在口服药物治疗基础上加用中药熏洗可提高治疗有效率和治愈率。
    Abstract: Objective To observe the effect of herbal fumigation on hand-foot syndrome after capecitabine chemotherapy. Methods Eighty-four colorectal cancer patients with Ⅱ degree of hand-foot syndrome induced by oral capecitabine for chemotherapy were randomly divided into control group and treatment group. Patients in the control group orally administrated vitamin B6 and mecobalamine, and those in the treatment group was additionally given herbal fumigation based on oral administration of drugs. The curative effects of the two groups were compared after treatment. Results The total effective rate was 64.3% in the control group, and 90.5% in the treatment group; the cure rate was 38.1% in the control group, and 66.7% in the treatment group, there were statistically significant differences in total effective rate and cure rate between the two groups(P<0.05). Conclusion Fumigation with traditional Chinese medicine based on oral administration of drugs can improve the effective rate and cure rate of hand-foot syndrome.
    • HTML全文
    • 参考文献(23)

  • FREDDIE B, JACQUES F, ISABELLE S, et al. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. A Cancer Journal for Clinicians, 2018, 20(1): 1-20.
    曹毛毛, 陈万青. 中国恶性肿瘤流行情况及防控现状[J]. 中国肿瘤临床, 2019, 46(3): 47-51.

    SIDDIQUI N S, GODARA A, BYRNE M M, et al. Capecitabine for the treatment of pancreatic cancer[J]. Expert Opinion on Pharmacotherapy, 2019: 1-11.

    LAM S W, GUCHELAAR H J, BOVEN E. The role of pharmacogenetics in capecitabine efficacy and toxicity[J]. Cancer Treatment Reviews, 2016: 20-30.

    SOO R A, SYN N, LEE S C, et al. Pharmacogenetics-Guided Phase Ⅰ Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid Tumours[J]. Scientific Reports, 2016, 6(1): 27826.

    SUTO T, ISHIGURO M, HAMADA C, et al. Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase Ⅲ study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage Ⅲ colon cancer[J]. International Journal of Clinical Oncology, 2017: 1-2.

    ILYAS S, WASIF K, SAIF M W. Topical henna ameliorated capecitabine-induced hand-foot syndrome[J]. Cutaneous and Ocular Toxicology, 2014, 33(3): 253-255.
    郭千弘, 马建瓴, 张炯, 等. 卡培他滨与5-氟尿嘧啶引起手足综合征的临床观察[J]. 中国医药指南, 2013, 15(31): 48-49

    , 51.

    GAOJ, HE Q, HUA D, et al. Polymorphism of TS 3'-UTR predicts survival of Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel[J]. clinical & translational oncology, 2013, 15(8): 619-625.

    FABIAN C J, MOLINA R, SLAVIK M, et al. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion[J]. Investigational New Drugs, 1990, 8(1): 57-63.

    LIN E, MORRIS J S, AYERS G D. Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity[J]. Oncology, 2002, 16(14): 31-37.

    ZHANG X J, WU D S, WAN Z H, et al. Celecoxib can prevent capecitabine-related hand-foot syndrome in stage Ⅱ and Ⅲ colorectal cancer patients: result of a single-center, prospective randomized phase Ⅲ trial[J]. Annals of oncology: official journal of the European Society for Medical Oncology, 2012, 23(5): 1348-53.
    李响, 刘铎, 吴东媛, 等. 卡培他滨相关基因多态性与手足综合征关系的研究进展[J]. 实用肿瘤学杂志, 2018, 32(2): 59-63.

    HAMZIC S, KUMMER D, MILESI S, et al. Novel genetic variants in carboxy lesterase 1 predict severe early-onset capecitabine-related toxicity[J]. Clinical Pharmacology & Therapeutics, 2017.

    MARTIN M, MARTINEZ N, RAMOS M, et al. Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer(GEICAM/2009-05): A Randomized, Noninferiority Phase Ⅱ Trial With a Pharmacogenetic Analysis[J]. Oncologist, 2015, 20(2): 111-112.

    PELLICER M, XANDRA. Identification of new SNPs associated with severe toxicity to capecitabine[J]. Pharmacological Research, 2017, 120: 133-137.
    李荣振, 张思森, 杨铁健, 等. CDA基因变异对卡培他滨治疗结直肠癌患者出现手足综合征的影响[J]. 中国肿瘤临床, 2018, 45(9): 458-461.

    JO S J, SHIN H, JO S, et al. Prophylactic and therapeutic efficacy of pyridoxine supplements in the management of hand-foot syndrome during chemotherapy: a meta-analysis[J]. Clinical and Experimental Dermatology, 2015, 40(3): 260-270.

    YAP Y S, KWOK L L, SYN N, et al. Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine–Induced Hand-Foot Syndrome[J]. JAMA Oncology, 2017, 29(6): 10-25.

    MACEDO, LIMA J P N, SANTOS L V D, et al. Prevention strategies for chemotherapy-induced hand-foot syndrome: A systematic review and meta-analysis of prospective randomised trials[J]. Supportive Care in Cancer, 2014, 22(6): 15-25.
    张晓迪, 陈嘉璐, 高静东. 温经化瘀方外治化疗相关性手足综合征的临床观察[J]. 浙江中医药大学学报, 2017, 41(2): 142-145.
    马燕妮, 廖文静, 张军辉, 等. 为使用卡培他滨的恶性肿瘤患者进行中药熏洗治疗对其手足综合征发生率的影响[J]. 当代医药论丛, 2019, 17(13): 208-209.
    董晶, 施航, 陆宁. 通阳活血方浸洗预防卡培他滨所致手足综合征临床观察[J]. 中国中医药科技, 2017, 24(6): 798-799.
    • 相关文章
    • 施引文献(18)

  • 期刊类型引用(11)

    1. 黄灵巧，李涛，胡颖颖，朱小燕. 芪藤通络汤熏洗治疗结直肠癌化疗后手足综合征的效果观察. 中国中医药科技. 2024(01): 96-97 . 百度学术
    2. 王丽，李金芬，易环，钟佳丽，靳枫，林奕霞，刘玉珍，黄凤霞. 卡培他滨导致Ⅱ-Ⅲ级手足综合征患者中药外敷护理的对照研究. 护理学报. 2024(11): 63-67 . 百度学术
    3. 邓兰，李志明，吴辉渊，江摩. 益气活血通络法联合艾灸对肿瘤化疗所致手足综合征及免疫功能的影响. 中国当代医药. 2023(01): 159-162 . 百度学术
    4. 黄婵，张亦，杨荣英. 黄芪及党参破壁饮片改善结直肠癌化疗患者不良反应的效果. 临床合理用药. 2023(10): 88-90 . 百度学术
    5. 黄晓琴，姚伟荣，孟晓晖，王凌，芦肖璠. 中药手足平联合核黄素防治索拉菲尼致手足皮肤反应的效果观察. 临床护理杂志. 2023(03): 71-74 . 百度学术
    6. 綦声波，高成业，秦万民. 皮下持续负压引流术联合中药口服对结直肠癌患者术后切口感染率、白细胞变化及免疫功能的影响. 中外医疗. 2023(19): 10-13+19 . 百度学术
    7. 姚金娥，管静，陈美玲，陈素红. 中药熏洗治疗抗肿瘤靶向药物所致手足综合征临床疗效研究. 系统医学. 2023(22): 100-103 . 百度学术
    8. 盛磊，林慧，仇妮，于春华. 翠云草总黄酮经环状RNA circ＿0006528通路抑制结直肠癌恶性生物学行为研究. 实用临床医药杂志. 2022(04): 106-113 . 本站查看
    9. 徐贞杰，李伟. 中药熏蒸临床研究进展. 中国疗养医学. 2022(06): 583-586 . 百度学术
    10. 罗凤，刘辉，王东梅，李红杰，周毅娟. 中药熏洗在胃肠道肿瘤化疗患者手足麻木中的应用. 临床研究. 2021(09): 120-122 . 百度学术
    11. 韩光明. 阳和解毒散外洗治疗多激酶抑制剂相关手足皮肤反应临床观察. 光明中医. 2021(23): 4009-4012 . 百度学术

    其他类型引用(7)

    • 资源附件(0)
计量
  • 文章访问数:  343
  • HTML全文浏览量:  124
  • PDF下载量:  40
  • 被引次数: 18
出版历程
  • 收稿日期:  2020-08-23
  • 网络出版日期:  2020-12-21
  • 发布日期:  2020-11-23

目录

摘要
HTML全文
    参考文献(23)
    相关文章
    施引文献
    资源附件(0)

    /

    返回文章
    返回

    © 2020 《实用临床医药杂志》编辑部

    地址：江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室邮编：225009电话：0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    本系统由 北京仁和汇智信息技术有限公司 开发  百度统计